Accretion Pharmaceuticals Ltd has initiated its initial public offering (IPO), aiming to raise Rs 29.75 crore by issuing 29.46 lakh new equity shares. The price band for the offering has been set between Rs 96 and Rs 101 per share. The subscription window opened on May 15 and will remain active through May 16. As of 2 p.m. on the first day, the issue had been subscribed 59%, reflecting moderate initial investor interest. Upon successful completion, the company plans to list its shares on the NSE SME platform, targeting enhanced visibility and access to public capital markets.